We are live on ! Find out more
HMC

Harvard Management Company Portfolio holdings

AUM $1.82B
1-Year Est. Return 26.23%
This Fund
S&P 500
This Quarter Est. Return
-20.41%
1 Year Est. Return
+26.23%
3 Year Est. Return
+156.3%
5 Year Est. Return
+133.98%
10 Year Est. Return
+221.37%
AUM
$864M
AUM Growth
-$127M
Cap. Flow
+$112M
Cap. Flow %
12.95%
Top 10 Hldgs %
81.94%
Holding
45
New
1
Increased
11
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$78.9M
2
ASML icon
ASML
ASML
+$11.3M
3
NVDA icon
NVIDIA
NVDA
+$7.56M
4
QRVO icon
Qorvo
QRVO
+$6.22M
5
AMD icon
Advanced Micro Devices
AMD
+$5.38M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$18.3M

Sector Composition

Rank Sector Weight
1 Communication Services 51.63%
2 Healthcare 17.75%
3 Consumer Discretionary 14.57%
4 Technology 11.74%
5 Industrials 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$3.91T
$263M 30.42%
2,411,540
+669,800
+38% +$78.9M
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$183M 21.21%
1,135,916
-95,103
-8% -$18.3M
LNW
3
DELISTED
Light & Wonder
LNW
$126M 14.57%
2,678,571
– –
ABCL icon
4
AbCellera Biologics
ABCL
$1.62B
$43.7M 5.06%
4,105,095
– –
EQRX
5
DELISTED
EQRx, Inc. Common Stock
EQRX
$24.7M 2.86%
5,262,161
– –
PCT icon
6
PureCycle Technologies
PCT
$1.17B
$18.5M 2.15%
2,498,170
– –
GRAB icon
7
Grab
GRAB
$13.5B
$13.6M 1.57%
5,369,919
+1,684,959
+46% +$4.84M
RVMD icon
8
Revolution Medicines
RVMD
$40.2B
$13.1M 1.51%
670,382
– –
RXRX icon
9
Recursion Pharmaceuticals
RXRX
$1.57B
$12.3M 1.42%
1,509,254
– –
NVDA icon
10
NVIDIA
NVDA
$5.01T
$10.1M 1.16%
663,680
+400,530
+152% +$7.56M
MEKA
11
DELISTED
MELI Kaszek Pioneer Corp Class A Ordinary Shares
MEKA
$9.9M 1.15%
1,000,000
– –
QRVO icon
12
Qorvo
QRVO
$7.63B
$9.87M 1.14%
104,669
+57,706
+123% +$6.22M
ASML icon
13
ASML
ASML
$675B
$9.61M 1.11%
+20,186
New +$11.3M
RLAY icon
14
Relay Therapeutics
RLAY
$4.02B
$9.06M 1.05%
541,124
– –
TSM icon
15
TSMC
TSM
$2.09T
$8.77M 1.02%
107,294
+42,851
+66% +$3.96M
AMD icon
16
Advanced Micro Devices
AMD
$851B
$8.57M 0.99%
112,137
+57,527
+105% +$5.38M
TXG icon
17
10x Genomics
TXG
$5.87B
$8.42M 0.98%
186,143
– –
LRCX icon
18
Lam Research
LRCX
$382B
$8.15M 0.94%
191,310
+66,100
+53% +$3.15M
AMAT icon
19
Applied Materials
AMAT
$426B
$8.05M 0.93%
88,443
+37,890
+75% +$4.16M
ADI icon
20
Analog Devices
ADI
$181B
$7.97M 0.92%
54,568
+12,829
+31% +$2.02M
INTC icon
21
Intel
INTC
$464B
$7.77M 0.9%
207,752
+56,946
+38% +$2.46M
KNTE
22
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$6.28M 0.73%
498,001
– –
MU icon
23
Micron Technology
MU
$1.04T
$5.94M 0.69%
107,522
+4,838
+5% +$329K
PLRX icon
24
Pliant Therapeutics
PLRX
$67.5M
$4.5M 0.52%
562,379
– –
NRIX icon
25
Nurix Therapeutics
NRIX
$2.43B
$3.99M 0.46%
314,762
– –
1
2

Similar funds

DWT
Dorsey & Whitney Trust Sioux Falls, South Dakota $1.82B AUM 19.69% 1-Year Est. Return
MCC
Money Concepts Capital Palm Beach Gardens, Florida $1.81B AUM 21.93% 1-Year Est. Return
ST
Spinnaker Trust Portland, Maine $1.81B AUM 17.83% 1-Year Est. Return
DE
Diversified Enterprises Wilmington, Delaware $1.83B AUM 16.79% 1-Year Est. Return
SI
Standard Investments New York $1.83B AUM 4.12% 1-Year Est. Return
WIC
Willis Investment Counsel Gainesville, Georgia $1.83B AUM 15.78% 1-Year Est. Return
GC
Gobi Capital San Francisco, California $1.8B AUM 7.28% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Harvard Management Company's Q2 2022 Portfolio in Review

As of Q2 2022, Harvard Management Company held 45 positions worth $864M, down 13% from $991M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Harvard Management Company deployed $112M of net new capital in Q2 2022, opening 1 new position and adding to 11 existing holdings. Its largest new stake was ASML: 20,186 shares worth $9.61M.

By sector, the portfolio is most concentrated in Communication Services at 52% of assets, down from 52% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $18.3M trimmed.

  • Harvard Management Company's largest Q2 2022 buy was ASML: 20,186 shares worth $9.61M.
  • Harvard Management Company added most to Alphabet (Google) Class A in Q2 2022, an estimated $78.9M increase.
  • Harvard Management Company's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $18.3M.
  • Harvard Management Company's ten largest holdings make up 82% of its $864M portfolio in Q2 2022.
  • Harvard Management Company opened 1 new position and closed 0 in Q2 2022.
  • Harvard Management Company's portfolio value fell 13% quarter-over-quarter to $864M.

Based on Harvard Management Company's 13F filing for Q2 2022, filed 12 Aug 2022.